Andrea Brendolan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea Brendolan has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Elisa Lenti
Lymphoid Stromal Cell Biology Unit Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute Milan Italy
5 shared publications- Giovanni Sitia
Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
4 shared publications - Luca G. Guidotti
Institute of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
3 shared publications Luca Genovese
Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
3 shared publications- Paolo Ghia
IRCSS Ospedale San Raffaele, Milan, Italy
3 shared publications Silvia Bianchessi
Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy
3 shared publications
Latest Publications
- 6 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
IFNAR1 stabilization sustains CD8 + T cell persistence in IFN-high colorectal cancer liver metastases
Colorectal cancer liver metastases (CRC-LMs) are associated with poor survival and frequently resist immunotherapy, yet the mechanisms underlying this immune refractoriness remain incompletely defined. Here, we identify a tumor-intrinsic type I interferon (IFN-I)–high state in CRC-LMs associated with loss of the IFN-α/β receptor subunit 1 (IFNAR1) on effector T lymphocytes within immune-enriched perimetastatic niches. Reduced IFNAR1 expression stratifies patients with poor clinical outcomes. Transcriptional profiling of patient-derived organoids and complementary preclinical models revealed heterogeneous but recurrent tumor-derived IFN-I production in CRC-LMs. In IFN-I high contexts, sustained signaling promoted IFNAR1 internalization on effector CD8 + T cells, impairing their persistence, survival, and effector function. Pharmacologic or genetic stabilization of IFNAR1 on cell surface restored CD8 + T cell fitness and selectively enhanced T cell receptor– and chimeric antigen receptor–based immunotherapies in IFN-I high tumors. These findings define a context-dependent IFN-I high / IFNAR1 low axis that constrains antitumor immunity in CRC-LMs and identify IFNAR1 stabilization as a strategy to convert chronic IFN signaling from a suppressive barrier into a therapeutic vulnerability.
- 6 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
IFNAR1 stabilization sustains CD8 + T cell persistence in IFN-high colorectal cancer liver metastases
Colorectal cancer liver metastases (CRC-LMs) are associated with poor survival and frequently resist immunotherapy, yet the mechanisms underlying this immune refractoriness remain incompletely defined. Here, we identify a tumor-intrinsic type I interferon (IFN-I)–high state in CRC-LMs associated with loss of the IFN-α/β receptor subunit 1 (IFNAR1) on effector T lymphocytes within immune-enriched perimetastatic niches. Reduced IFNAR1 expression stratifies patients with poor clinical outcomes. Transcriptional profiling of patient-derived organoids and complementary preclinical models revealed heterogeneous but recurrent tumor-derived IFN-I production in CRC-LMs. In IFN-I high contexts, sustained signaling promoted IFNAR1 internalization on effector CD8 + T cells, impairing their persistence, survival, and effector function. Pharmacologic or genetic stabilization of IFNAR1 on cell surface restored CD8 + T cell fitness and selectively enhanced T cell receptor– and chimeric antigen receptor–based immunotherapies in IFN-I high tumors. These findings define a context-dependent IFN-I high / IFNAR1 low axis that constrains antitumor immunity in CRC-LMs and identify IFNAR1 stabilization as a strategy to convert chronic IFN signaling from a suppressive barrier into a therapeutic vulnerability.
- Open Access
- 7 October 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 4 (1)
Influence of gut microbiota on chronic lymphocytic leukemia development and aggressiveness
Chronic lymphocytic leukemia (CLL) represents the most common leukemia in the adult population in the Western world, while it is very rare in Asia, suggesting a geographical heterogeneity. 1 CLL is...
- 7 October 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 4 (1)
Open AccessInfluence of gut microbiota on chronic lymphocytic leukemia development and aggressiveness
Chronic lymphocytic leukemia (CLL) represents the most common leukemia in the adult population in the Western world, while it is very rare in Asia, suggesting a geographical heterogeneity. 1 CLL is...
- 1 August 2025
- Published by The Company of Biologists in Development
- Vol. 152 (15)
Origin and differentiation of lymph node and spleen progenitors during embryonic development
Secondary lymphoid tissues, including the spleen and lymph nodes, play an essential role in supporting immune responses. These organs are structurally organized into specialized compartments in which the interactions between hematopoietic and stromal cells are crucial for immune cell function. In this Review, we examine the cellular and molecular mechanisms that control spleen and lymph nodes, primarily in mice, with a particular emphasis on the embryonic origins of the different cell types involved. We also discuss the processes that determine the acquisition of lymphoid and mesenchymal cell fate in these tissues, as well as the developmental relationships between embryonic progenitor cells and mature stromal cells. In addition, we address the importance of understanding the sources of progenitor cells in the context of organogenesis and highlight several unresolved questions.
- 1 August 2025
- Published by The Company of Biologists in Development
- Vol. 152 (15)
Origin and differentiation of lymph node and spleen progenitors during embryonic development
Secondary lymphoid tissues, including the spleen and lymph nodes, play an essential role in supporting immune responses. These organs are structurally organized into specialized compartments in which the interactions between hematopoietic and stromal cells are crucial for immune cell function. In this Review, we examine the cellular and molecular mechanisms that control spleen and lymph nodes, primarily in mice, with a particular emphasis on the embryonic origins of the different cell types involved. We also discuss the processes that determine the acquisition of lymphoid and mesenchymal cell fate in these tissues, as well as the developmental relationships between embryonic progenitor cells and mature stromal cells. In addition, we address the importance of understanding the sources of progenitor cells in the context of organogenesis and highlight several unresolved questions.
- Open Access
- 7 July 2025
- Published by Wiley in HemaSphere
- Vol. 9 (7) , e70170
A spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) B cells are characterized by a propensity to undergo rapid apoptosis when cultured in vitro, underscoring the importance of the tissue microenvironment for disease survival. One of the major limitations in studying the role of the microenvironment in tumor development and drug response is the inadequacy of conventional two‐dimensional (2D) in vitro assays to physiologically reconstruct the complex spatial organization and interactions of cells in their natural lymphoid niches. To overcome this limitation, we developed a novel in vitro 3D lymph node‐like spheroid model of the leukemic microenvironment by culturing human CLL cells with fibroblastic reticular cells (FRCs). FRCs are a key structural component of secondary lymphoid organs and are emerging as crucial players in tissue homeostasis and immune responses. Our results demonstrate that CLL spheroids maintain the physiological cellular ratio between FRCs and leukemic cells over time and protect tumor cells from apoptosis by mimicking the protective effects of the microenvironment. This was further demonstrated by venetoclax treatment that showed reduced apoptosis in 3D compared to a 2D setting. Importantly, the spheroids promote a gene expression profile more aligned with that of CLL cells in lymphoid tissues. The spheroid model provides a straightforward, quick‐to‐use platform for investigating drug efficacy under conditions that better replicate the natural lymph node microenvironment. This 3D lymph node‐like spheroid model could serve as a valuable tool for studying tumor biology and the protective effects of the stromal microenvironment, and for testing therapeutic strategies in a more clinically relevant setting.
- 7 July 2025
- Published by Wiley in HemaSphere
- Vol. 9 (7) , e70170
Open AccessA spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) B cells are characterized by a propensity to undergo rapid apoptosis when cultured in vitro, underscoring the importance of the tissue microenvironment for disease survival. One of the major limitations in studying the role of the microenvironment in tumor development and drug response is the inadequacy of conventional two‐dimensional (2D) in vitro assays to physiologically reconstruct the complex spatial organization and interactions of cells in their natural lymphoid niches. To overcome this limitation, we developed a novel in vitro 3D lymph node‐like spheroid model of the leukemic microenvironment by culturing human CLL cells with fibroblastic reticular cells (FRCs). FRCs are a key structural component of secondary lymphoid organs and are emerging as crucial players in tissue homeostasis and immune responses. Our results demonstrate that CLL spheroids maintain the physiological cellular ratio between FRCs and leukemic cells over time and protect tumor cells from apoptosis by mimicking the protective effects of the microenvironment. This was further demonstrated by venetoclax treatment that showed reduced apoptosis in 3D compared to a 2D setting. Importantly, the spheroids promote a gene expression profile more aligned with that of CLL cells in lymphoid tissues. The spheroid model provides a straightforward, quick‐to‐use platform for investigating drug efficacy under conditions that better replicate the natural lymph node microenvironment. This 3D lymph node‐like spheroid model could serve as a valuable tool for studying tumor biology and the protective effects of the stromal microenvironment, and for testing therapeutic strategies in a more clinically relevant setting.
- Open Access
- 25 October 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier
Hepatic metastases are a poor prognostic factor of colorectal carcinoma (CRC) and new strategies to reduce the risk of liver CRC colonization are highly needed. Herein, we used mouse models of hepatic metastatization to demonstrate that the continuous infusion of therapeutic doses of interferon-alpha (IFNα) controls CRC invasion by acting on hepatic endothelial cells (HECs). Mechanistically, IFNα promoted the development of a vascular antimetastatic niche characterized by liver sinusoidal endothelial cells (LSECs) defenestration extracellular matrix and glycocalyx deposition, thus strengthening the liver vascular barrier impairing CRC trans-sinusoidal migration, without requiring a direct action on tumor cells, hepatic stellate cells, hepatocytes, or liver dendritic cells (DCs), Kupffer cells (KCs) and liver capsular macrophages (LCMs). Moreover, IFNα endowed LSECs with efficient cross-priming potential that, along with the early intravascular tumor burden reduction, supported the generation of antitumor CD8+ T cells and ultimately led to the establishment of a protective long-term memory T cell response. These findings provide a rationale for the use of continuous IFNα therapy in perioperative settings to reduce CRC metastatic spreading to the liver.
- 25 October 2022
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 11
Open AccessContinuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier
Hepatic metastases are a poor prognostic factor of colorectal carcinoma (CRC) and new strategies to reduce the risk of liver CRC colonization are highly needed. Herein, we used mouse models of hepatic metastatization to demonstrate that the continuous infusion of therapeutic doses of interferon-alpha (IFNα) controls CRC invasion by acting on hepatic endothelial cells (HECs). Mechanistically, IFNα promoted the development of a vascular antimetastatic niche characterized by liver sinusoidal endothelial cells (LSECs) defenestration extracellular matrix and glycocalyx deposition, thus strengthening the liver vascular barrier impairing CRC trans-sinusoidal migration, without requiring a direct action on tumor cells, hepatic stellate cells, hepatocytes, or liver dendritic cells (DCs), Kupffer cells (KCs) and liver capsular macrophages (LCMs). Moreover, IFNα endowed LSECs with efficient cross-priming potential that, along with the early intravascular tumor burden reduction, supported the generation of antitumor CD8+ T cells and ultimately led to the establishment of a protective long-term memory T cell response. These findings provide a rationale for the use of continuous IFNα therapy in perioperative settings to reduce CRC metastatic spreading to the liver.
- Open Access
- 1 June 2019
- Published by Elsevier in Stem Cell Reports
- Vol. 12 (6) , 1260-1268
Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation
- 1 June 2019
- Published by Elsevier in Stem Cell Reports
- Vol. 12 (6) , 1260-1268
Open AccessTherapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation
- 1 June 2018
- Published by Elsevier in Trends in Immunology
- Vol. 39 (6) , 503-514
Origin and Immunological Functions of Spleen Stromal Cells
- 1 June 2018
- Published by Elsevier in Trends in Immunology
- Vol. 39 (6) , 503-514
Origin and Immunological Functions of Spleen Stromal Cells
- Open Access
- 3 May 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-12
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression
In chronic lymphocytic leukemia (CLL), the non-hematopoietic stromal microenvironment plays a critical role in promoting tumor cell recruitment, activation, survival, and expansion. However, the nature of the stromal cells and molecular pathways involved remain largely unknown. Here, we demonstrate that leukemic B lymphocytes induce the activation of retinoid acid synthesis and signaling in the microenvironment. Inhibition of RA-signaling in stromal cells causes deregulation of genes associated with adhesion, tissue organization and chemokine secretion including the B-cell chemokine CXCL13. Notably, reducing retinoic acid precursors from the diet or inhibiting RA-signaling through retinoid-antagonist therapy prolong survival by preventing dissemination of leukemia cells into lymphoid tissues. Furthermore, mouse and human leukemia cells could be distinguished from normal B-cells by their increased expression ofRarγ2andRXRα,respectively. These findings establish a role for retinoids in murine CLL pathogenesis, and provide new therapeutic strategies to target the microenvironment and to control disease progression.
- 3 May 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-12
Open AccessA retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression
In chronic lymphocytic leukemia (CLL), the non-hematopoietic stromal microenvironment plays a critical role in promoting tumor cell recruitment, activation, survival, and expansion. However, the nature of the stromal cells and molecular pathways involved remain largely unknown. Here, we demonstrate that leukemic B lymphocytes induce the activation of retinoid acid synthesis and signaling in the microenvironment. Inhibition of RA-signaling in stromal cells causes deregulation of genes associated with adhesion, tissue organization and chemokine secretion including the B-cell chemokine CXCL13. Notably, reducing retinoic acid precursors from the diet or inhibiting RA-signaling through retinoid-antagonist therapy prolong survival by preventing dissemination of leukemia cells into lymphoid tissues. Furthermore, mouse and human leukemia cells could be distinguished from normal B-cells by their increased expression ofRarγ2andRXRα,respectively. These findings establish a role for retinoids in murine CLL pathogenesis, and provide new therapeutic strategies to target the microenvironment and to control disease progression.
- 10 June 2016
- Published by Springer Nature
- p. 121-133
Spleen Development and the Origin of Stromal Diversity
- 10 June 2016
- Published by Springer Nature
- p. 121-133
Spleen Development and the Origin of Stromal Diversity